NASDAQ:MLAB - Mesa Laboratories Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $287.00
  • Forecasted Upside: -5.96 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$305.20
▼ -1.8 (-0.59%)

This chart shows the closing price for MLAB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Mesa Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLAB

Analyst Price Target is $287.00
▼ -5.96% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Mesa Laboratories in the last 3 months. The average price target is $287.00, with a high forecast of $287.00 and a low forecast of $287.00. The average price target represents a -5.96% upside from the last price of $305.20.

This chart shows the closing price for MLAB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in Mesa Laboratories. This rating has held steady since October 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$287.00High
10/2/2020JPMorgan Chase & Co.Initiated CoverageNeutral$260.00Low
12/4/2019Jefferies Financial GroupInitiated CoverageBuy$275.00 ➝ $275.00High
8/26/2019Evercore ISIInitiated CoverageOutperform$250.00High
3/13/2019SidotiInitiated CoverageNeutralHigh
12/23/2016Janney Montgomery ScottReiterated RatingBuyN/A
(Data available from 10/27/2016 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
8/28/2021
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/27/2021
  • 3 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
10/27/2021

Current Sentiment

  • 3 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mesa Laboratories logo
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Read More

Today's Range

Now: $305.20
Low: $302.54
High: $309.12

50 Day Range

MA: $290.03
Low: $266.92
High: $322.44

52 Week Range

Now: $305.20
Low: $232.88
High: $325.50

Volume

26,091 shs

Average Volume

27,371 shs

Market Capitalization

$1.59 billion

P/E Ratio

412.43

Dividend Yield

0.21%

Beta

0.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Mesa Laboratories?

The following sell-side analysts have issued research reports on Mesa Laboratories in the last twelve months: KeyCorp, and Zacks Investment Research.
View the latest analyst ratings for MLAB.

What is the current price target for Mesa Laboratories?

1 Wall Street analysts have set twelve-month price targets for Mesa Laboratories in the last year. Their average twelve-month price target is $287.00, suggesting a possible downside of 6.5%. KeyCorp has the highest price target set, predicting MLAB will reach $287.00 in the next twelve months. KeyCorp has the lowest price target set, forecasting a price of $287.00 for Mesa Laboratories in the next year.
View the latest price targets for MLAB.

What is the current consensus analyst rating for Mesa Laboratories?

Mesa Laboratories currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MLAB, but not buy more shares or sell existing shares.
View the latest ratings for MLAB.

What other companies compete with Mesa Laboratories?

Other companies that are similar to Mesa Laboratories include Cognex, Coherent, National Instruments, Itron, Badger Meter, OSI Systems, FARO Technologies, Vishay Precision Group and Daktronics.

How do I contact Mesa Laboratories' investor relations team?

Mesa Laboratories' physical mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier's listed phone number is (303) 987-8000 and its investor relations email address is [email protected] The official website for Mesa Laboratories is www.mesalabs.com.